secwatch.observer — SEC 8-K summary
======================================

Issuer:     Harmony Biosciences Holdings, Inc. (HRMY)
CIK:        0001802665
Form:       8-K
Filed at:   2023-07-27T23:59:59+00:00
Accession:  0001558370-23-012348
Event type: debt
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 1.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Harmony Bio refinances with $185M term loan, repays $196.5M debt, saves ~$6M/year interest
--------------------------------------------------------------------------------

- New $185M senior secured term loan from JPMorgan-led syndicate, matures July 26, 2028.
- Proceeds plus cash used to fully repay $196.5M existing Blackstone loan; paid 2% prepayment premium.
- Annual interest expense reduction of approximately $6 million from lower cost of capital.
- Quarterly principal payments: $3.5M starting Dec 31, 2023, stepping to $4.6M after Dec 31, 2025.
- Loan priced at SOFR plus 0.10% credit spread plus 3.50%-4.00% margin (or base rate plus 2.50%-3.00%).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1802665/000155837023012348/0001558370-23-012348-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1802665/000155837023012348/hrmy-20230726x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-012348

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer